Skip to main content

Table 3 Estimated age parameters (A α) by cancer site, age and sex

From: Global and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by site

 

Oral

Oesophagus

Stomach

Colon and rectum

Liver

Pancreas

Age

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female

0–4

0.870

1.093

0.957

0.944

0.864

0.814

1.169

0.288

0.330

0.388

0.824

0.408

5–9

0.429

0.222

0.957

0.944

0.864

0.814

1.169

0.288

0.430

0.600

0.824

0.408

10–14

0.216

0.258

0.957

0.944

0.864

0.814

1.169

0.288

0.527

0.315

0.824

0.613

15–19

0.185

0.200

0.957

0.944

0.864

0.814

1.169

0.688

0.225

0.585

0.824

0.204

20–24

0.337

0.099

0.957

0.944

0.864

0.895

1.169

0.467

0.580

0.638

0.824

0.204

25–29

0.710

0.177

0.957

0.944

0.864

0.888

1.169

0.820

0.818

0.689

0.824

0.531

30–34

0.913

0.314

0.957

0.944

0.864

0.685

1.169

0.590

0.949

0.773

0.824

0.497

35–39

0.761

0.436

0.957

0.888

0.864

0.811

0.966

0.700

0.960

0.752

0.893

0.712

40–44

0.818

0.526

0.957

0.985

0.864

0.746

0.765

0.739

1.033

0.780

0.907

0.745

45–49

0.883

0.631

0.965

0.977

0.931

0.791

0.787

0.687

0.974

0.819

0.927

0.902

50–54

0.908

0.894

0.969

1.036

0.899

0.851

0.784

0.671

0.980

0.969

0.936

0.922

55–59

0.936

0.939

0.948

0.996

0.877

0.816

0.797

0.739

1.010

0.962

0.977

0.952

60–64

1.017

0.884

0.967

0.959

0.940

0.863

0.812

0.749

1.023

0.998

0.986

0.970

65–69

1.048

1.086

1.029

0.949

0.972

0.923

0.861

0.857

1.010

1.025

1.015

0.989

70–74

1.145

1.103

1.038

0.975

0.990

0.982

0.979

0.898

1.051

1.034

1.016

1.020

75–79

1.141

1.304

1.063

0.969

1.082

1.055

1.134

1.069

1.032

1.082

1.016

1.033

80–84

1.220

1.354

1.096

1.066

1.169

1.121

1.368

1.275

1.070

1.126

1.061

1.058

85+

1.358

1.993

1.152

1.210

1.259

1.279

1.793

1.619

1.039

1.126

1.082

1.084

 

Lung

Bladder

Non-Hodgkin lymphoma

Hodgkin lymphoma

Multiple myeloma

Leukaemia

Age

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female

Male

Female

0–4

0.711

0.849

0.107

0.141

0.824

0.823

0.476

0.000

1.000

1.000

0.356

0.354

5–9

0.711

0.849

0.107

0.141

0.716

0.502

0.304

0.972

1.000

1.000

0.280

0.224

10–14

0.711

0.849

0.107

0.141

0.791

0.664

0.226

0.493

1.000

1.000

0.483

0.525

15–19

0.711

0.849

0.107

0.141

0.850

0.859

0.159

0.191

1.000

1.000

0.703

0.684

20–24

0.711

0.849

0.107

0.141

0.953

0.767

0.303

0.204

1.000

1.000

0.865

0.815

25–29

0.711

0.849

0.107

0.159

1.261

0.673

0.280

0.161

0.431

0.318

0.883

0.936

30–34

0.926

0.849

0.182

0.393

1.381

0.677

0.507

0.259

0.670

0.619

0.814

0.796

35–39

0.939

0.849

0.157

0.533

1.320

0.565

0.492

0.422

0.485

0.540

0.866

0.872

40–44

0.922

0.890

0.344

0.459

1.107

0.521

0.794

0.346

0.591

0.622

0.702

0.801

45–49

0.909

0.891

0.443

0.452

0.872

0.526

1.145

0.744

0.556

0.525

0.770

0.882

50–54

0.920

0.891

0.459

0.405

0.715

0.576

1.262

1.084

0.700

0.725

0.780

0.830

55–59

0.932

0.918

0.550

0.522

0.713

0.630

1.401

1.683

0.684

0.669

0.811

0.829

60–64

0.954

0.937

0.756

0.637

0.809

0.760

2.194

2.317

0.800

0.785

0.899

0.880

65–69

0.986

0.979

0.751

0.764

0.860

0.877

2.581

3.020

0.898

0.762

0.991

0.959

70–74

1.039

1.038

1.069

0.878

1.003

1.058

3.753

3.912

1.139

0.942

1.192

1.068

75–79

1.090

1.038

1.305

1.199

1.251

1.428

4.263

4.686

1.231

1.196

1.404

1.185

80–84

1.169

1.038

1.740

1.520

1.531

1.654

4.979

4.303

1.535

1.451

1.501

1.337

85+

1.219

1.038

2.453

1.956

1.863

2.105

5.372

6.393

1.828

1.743

1.563

1.535

 

Melanoma

Miscellaneous

Breast

Cervix

Uterus

Ovary

Prostate

   

Age

Male

Female

Male

Female

Female

Female

Female

Female

Male

   

0–4

1.000

3.573

0.514

0.430

0.874

0.574

0.322

0.247

0.548

   

5–9

1.000

1.000

0.444

0.405

0.874

0.574

0.322

0.247

0.548

   

10–14

0.324

0.706

0.395

0.299

0.874

0.574

0.322

0.247

0.548

   

15–19

0.959

0.937

0.377

0.222

0.874

0.574

0.322

0.202

0.548

   

20–24

0.670

0.531

0.279

0.147

0.874

0.425

0.322

0.241

0.548

   

25–29

0.764

0.455

0.229

0.154

0.679

0.329

0.553

0.173

0.548

   

30–34

0.564

0.493

0.261

0.207

0.733

0.406

0.382

0.236

0.548

   

35–39

0.902

0.542

0.375

0.270

0.651

0.457

0.353

0.336

0.548

   

40–44

0.857

0.769

0.527

0.400

0.569

0.508

0.458

0.433

0.548

   

45–49

0.871

0.710

0.709

0.498

0.564

0.739

0.411

0.496

0.548

   

50–54

0.815

1.073

0.850

0.620

0.790

0.994

0.473

0.614

0.548

   

55–59

1.110

0.769

0.957

0.741

0.954

1.025

0.610

0.808

0.548

   

60–64

1.087

1.297

1.072

0.852

0.933

1.218

0.701

0.955

0.551

   

65–69

1.093

1.150

1.226

0.954

1.067

1.366

0.901

1.089

0.508

   

70–74

0.988

1.507

1.375

1.076

1.092

1.740

1.219

1.369

0.508

   

75–79

1.425

2.241

1.523

1.219

1.215

2.259

1.629

1.650

1.083

   

80–84

1.620

1.909

1.714

1.372

1.513

2.729

2.570

1.650

1.876

   

85+

2.008

2.738

1.914

1.555

2.438

3.358

3.705

1.650

1.876

   
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us